Centre hospitalier universitaire de Sherbrooke (CHUS)

Sherbrooke, Quebec J1H 5N4

0 studies enrolling now · 7 studies all time

What they study most

Acute Respiratory Distress Syndrome (ARDS), Coronary Artery Disease, Hyperlipidemia, IgG4 Related Disease, Myocardial Infarction, Overactive Bladder, Sudden Death, Ventricular Arrhythmia

Studies at this site

• A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease — Running, not enrolling
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. — Completed
• Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator — Completed
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial — Stopped early